Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-02-20 @ 4:45 PM
Study NCT ID:
NCT00618956
Status:
COMPLETED
Last Update Posted:
2009-11-20
First Post:
2008-01-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring
Sponsor:
Forest Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MLN-MD-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Allan Spera, Director
Old Organization:
Forest Laboratories, Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |